Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease-Reference-Cited by-同舟云学术

Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease

Published:2022-06-02 Issue:10 Volume:27 Page:854-862
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Zheng Boyang¹²^ORCID,Donohoe Kathryn²,Hambly Nathan³,Johannson Kerri A.⁴,Assayag Deborah⁵,Fisher Jolene H.⁶^ORCID,Manganas Helene⁷,Marcoux Veronica⁸,Khalil Nasreen²,Kolb Martin³^ORCID,Ryerson Christopher J.²⁹^ORCID,Wong Alyson W.,Lok Stacey,Morisset Julie,Fell Charlene D.,Shapera Shane,Gershon Andrea S.,Cox Gerard,Halayko Andrew J.,Sadatsafavi Mohsen,Wilcox Pearce G.,To Teresa,

Affiliation:

1. Division of Rheumatology McGill University Montreal Quebec Canada

2. Department of Medicine University of British Columbia Vancouver British Columbia Canada

3. Department of Medicine McMaster University Hamilton Ontario Canada

4. Department of Medicine University of Calgary Calgary Alberta Canada

5. Department of Medicine McGill University Montreal Quebec Canada

6. Department of Medicine University of Toronto Toronto Ontario Canada

7. Department of Medicine Université de Montréal Montreal Quebec Canada

8. Department of Medicine University of Saskatchewan Saskatoon Saskatchewan Canada

9. Centre for Heart Lung Innovation St. Paul's Hospital Vancouver British Columbia Canada

Funder

Boehringer Ingelheim